AK Medical Holdings Limited released its Monthly Return for Equity Issuer for the period ended 31 August 2026, highlighting a largely stable capital base with minimal changes to issued share capital and continued compliance with Hong Kong’s public-float requirements.
Authorised Capital • Authorised share capital remained unchanged at 2.00 billion ordinary shares with a par value of HK$0.01 each, equivalent to HK$20.00 million.
Issued and Treasury Shares • Outstanding shares rose by 72,698 to 1,093.28 million, a marginal lift of 0.01% versus July’s closing balance. • Treasury stock was steady at 32.26 million shares, keeping total issued share capital at 1,125.54 million shares. • The issuer reaffirmed that its public-float ratio stays above the 25% threshold mandated by Hong Kong Listing Rules.
Equity Movements During the Month • The entire monthly increase stemmed from the exercise of 72,698 share options granted at an exercise price of HK$4.66 per share, generating HK$0.34 million in cash proceeds. • No new treasury shares were transferred or cancelled during August.
Share Repurchases Pending Cancellation • A cumulative 15.56 million shares repurchased between 6 February and 8 June 2026 remain outstanding for cancellation as at 31 August 2026, with no additional repurchases reported during the month.
Outstanding Share Options • Post-exercise, 5.44 million options remain outstanding across four schemes: – Pre-IPO Scheme: 0.50 million options at HK$1.34 – 2019 Scheme: 3.56 million options at HK$4.66 – 2020 Scheme: 1.03 million options at HK$10.18 – 2021 Scheme: 0.36 million options at HK$5.85 These collectively represent approximately 0.48% of the company’s enlarged issued share capital.
Liquidity and Governance • The company’s confirmation of adequate public float and compliance with all Hong Kong Stock Exchange listing obligations underscores adherence to regulatory standards.
The August update signals disciplined equity management, with only nominal dilution from option exercises and an anticipated reduction in outstanding shares once the previously repurchased stock is formally cancelled.